Dr. Hadaschik on Treatment After Apalutamide Progression in SPARTAN TrialByBoris A. Hadaschik, MDFebruary 16th 2023Boris A. Hadaschik, MD, discusses a post-hoc analysis of subsequent therapies received by patients with prostate cancer treated with apalutamide during the phase 3 SPARTAN trial.